Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca    AZN   GB0009895292

ASTRAZENECA

(AZN)
Add to my list  
My previous session
Most popular
Manage my lists
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Larger Image
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201620172018201920202021
Sales23 00222 46522 09023 42825 79328 262
EBITDA9 0789 8919 4258 0219 41810 411
Operating profit (EBIT)6 7216 8555 6726 1227 5418 614
Pre-Tax Profit (EBT)3 4062 227-3 4674 8846 447
Net income3 4993 0012 1552 8064 1475 576
P/E ratio19,829,244,036,425,520,5
EPS ( $ )2,772,371,702,213,153,92
Dividend per Share ( $ )2,802,802,802,742,813,07
Yield5,11%4,05%3,74%3,40%3,50%3,82%
Reference price ( $ )54.869.174.980.439880.439880.4398
Announcement Date02/02/2017
08:11am		02/02/2018
07:00am		02/14/2019
07:00am		---
Finances - Leverage
Larger Image
Actuals in M $ Estimates in M $
Fiscal Period December 201620172018201920202021
Debt11 79014 483-14 78114 89213 794
Finance------
Operating income (EBITDA)9 0789 8919 4258 0219 41810 411
Leverage
(Debt/EBITDA)		1,30x1,46x-1,84x1,58x1,32x
Capital Expenditure1 4461 326-1 2571 3781 392
Book Value Per Share (BVPS)11,7 $--10,7 $9,87 $10,3 $
Cash Flow per Share3,27 $2,82 $2,07 $3,77 $4,98 $5,53 $
Announcement Date02/02/2017
08:11am		02/02/2018
07:00am		02/14/2019
07:00am		---
Balance Sheet Analysis
Larger Image
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2019e 2020e
Capitalization 101 309 M$ -
Entreprise Value (EV) 116 090 M$ 116 201 M$
Valuation 2019e 2020e
P/E ratio (Price / EPS) 36,4x 25,5x
Capitalization / Revenue 4,32x 3,93x
EV / Revenue 4,96x 4,51x
EV / EBITDA 14,5x 12,3x
Yield (DPS / Price) 3,40% 3,50%
Price to book (Price / BVPS) 7,55x 8,15x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 26,1% 29,2%
operating Leverage (Delta EBIT / Delta Sales) 1,31x 2,30x
Net Margin (Net Profit / Revenue) 12,0% 16,1%
ROA (Net Profit / Asset) 5,70% 8,34%
ROE (Net Profit / Equities) 30,5% 46,1%
Rate of Dividend 124% 89,3%
Balance Sheet Analysis 2019e 2020e
CAPEX / CA   5,37% 5,34%
Cash Flow / Sales 20,4% 24,5%
Capital Intensity (Assets / Sales) 2,10x 1,93x
Financial Leverage (Net Debt / EBITDA) 1,84x 1,58x
Price Earning Ratio
Help 
The blue ligne is the average P/E ratio (without estimates)
Larger Image
EPS & Dividend
Larger Image
MarketScreener.com :
About :
Stay Connected :
Partners :
Copyright © 2019 Surperformance. All rights reserved.